Skip to main content
. 2013 Jul 17;17(5):838–844. doi: 10.1093/icvts/ivt292

Table 6:

Univariate analysis for complications

Global complications
No, n = 151, n (%) Yes, n = 77, n (%) P-value
Age
 <70 115 (67.3) 56 (32.7) 0.573
 ≥70 36 (63.2) 21 (36.8)
Gender
 Female 77 (75.8) 26 (25.2) 0.013
 Male 74 (59.2) 51 (40.8)
Smoker status
 Active 38 (57.6) 29 (42.4) 0.078
 Former >6 month 48 (65.8) 26 (34.2) 0.918
 Never 63 (74.1) 22 (25.9) 0.052
Comorbidities
 Cardiovascular 12 (54.5) 10 (45.5) 0.224
 Diabetes mellitus 12 (50.0) 12 (50.0) 0.076
 Previous pulmonary resection 37 (64.9) 20 (35.1) 0.809
 No comorbidities 36 (76.6) 11 (23.4) 0.092
FEV1
 FEV1 ≤ 60% 9 (30.0) 21 (70.0) <0.001
 60% < FEV1 < 80% 30 (65.2) 16 (34.8)
 FEV1 ≥ 80% 113 (74.3) 39 (25.7)
Indication
 Cancer 73 (65.8) 38 (34.2) 0.886
 Metastasis 45 (63.4) 26 (36.6) 0.543
 Benign non-infectious 20 (80.0) 5 (20.0) 0.124
 Benign infectious 13 (61.9) 8 (38.1) 0.662
Surgical approach
 Thoracotomy 85 (58.2) 61 (41.8) 0.001
 Thoracoscopy 66 (80.5) 16 (19.5)
 Mean duration of surgery (min) 142.2 142.7 0.337

FEV1: forced expiratory volume in 1 s.